PROM1 and acute lymphoblastic leukemia: While several studies have shown no significant association of CD133+ expression with age, gender, or clinical characteristics, e.g., percentage of leukemic blast cells in peripheral blood/bone marrow of ALL patients, CD133+ ALL cells have shown a higher degree of immaturity [22].